## Abstract Whereas human herpesvirus 6 (HHV‐6) reactivation is frequent in solid organ transplant recipients, symptomatic disease is rare. A case of colitis associated with HHV‐6B reactivation was observed in a lung transplant recipient. This case report suggests that symptomatic HHV‐6 infection m
Case report: Human herpesvirus 7 associated fatal encephalitis in a peripheral blood stem cell transplant recipient
✍ Scribed by Dr. Paul K.S. Chan; Ki-Wai Chik; Ka-Fai To; Chi-Kong Li; Matthew M.K. Shing; King-Cheung Ng; Patrick M.P. Yuen; Augustine F. Cheng
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 103 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0146-6615
- DOI
- 10.1002/jmv.2171
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Previous studies have suggested a neuroinvasive and neuropersistent potential of human herpesvirus 7 (HHV‐7). In this report, a case of fatal encephalitis is described and its association with HHV‐7 infection is discussed. An 8‐year‐old girl received a peripheral blood stem cell transplant for relapsed acute lymphoblastic leukaemia. The post‐transplant period was uneventful and a course of intrathecal chemotherapy was given on Day‐30. On Day‐41, she developed acute encephalopathy with diplopia and nystagmus. She ran a rapid downhill course and succumbed despite antiviral treatment. The only positive pathological finding was the multiple microscopic foci of haemorrhage associated with neuronal degeneration detected in the brain stem. All microbiological investigations were negative, except for the presence of HHV‐7 DNA in cerebrospinal fluid and brain stem tissue samples. J. Med. Virol. 66:493–496, 2002. © 2002 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Human herpesvirus 6 (HHV-6) is a common pathogen among children, classically presenting as fever and rash that resolve without specific therapy (exanthem subitum or roseola infantum). Also identified as a pathogen in hematopoietic cell transplant and solid organ transplant (SOT) recipients, it has b
## Abstract A 9‐year‐old boy who received allogeneic stem cell transplantation began to vomit from day 10 after transplantation. In addition to vomiting, the patient had a fever (from day 26) and severe headache (from day 34). His cerebrospinal fluid (CSF) (day 41) demonstrated pleocytosis with an